
    
      This study is designed to evaluate the safety and efficacy of Asacol® 2.4 g/day in generally
      healthy, adult patients who have had an attack of acute diverticulitis. The study will
      evaluate the safety and efficacy of a 12 week treatment with Asacol® followed a 9 month
      non-treatment observation period in approximately 180 patients with acute diverticulitis.
    
  